Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT07224204
- Status
- Recruiting
Conditions
- Adolescent Cancer
- Cancer
- Young Adult Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - 39 Years
- Healthy Volunteers
- Not accepted
Interventions
- Life at 100.4 — BEHAVIORALAn Immersive Social Virtual Reality Education Tool, participation up to 2 hours
Study Details
The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.
Key Dates
- Start date
- Feb 11, 2026
- Status verified
- Feb 2026
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 45 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- No Intervention: Objective 1: Focus groupsParticipants will participate in a 45 minute to 1-hour long focus group with similar stake holders to inform the intervention. These groups will take place via Zoom teleconferencing software, have 4-6 participants per group and will be run by appropriately trained study staff.
- Experimental: Objective 3:Beta testing of VR-based educational intervention, Life at 100.4, to improve understanding of fever with neutropenia, how and when to check for it, and what to do when they have a fever.
Primary Outcome Measure
Multimodal Presence Scale for Virtual Environments [ Time Frame: immediately post-intervention, up to 2 hours ]
Central Contacts
- Asher Marks, MD203-785-4640
- Vidya Puthepura, MD203-785-4640
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Pediatric Hematology/Oncology Clinic in Smilow Cancer Hospital | New Haven | Connecticut | 06520 | - |
Find similar trials in New Haven, CT
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Pan Tumor Rollover StudyPHASE2 · Recruiting · Bristol-Myers Squibb · Huntsville, Alabama
- TTX-080 HLA-G Antagonist in Subjects With Advanced CancersPHASE1 · Recruiting · Tizona Therapeutics, Inc · Tucson, Arizona
- Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067PHASE1/PHASE2 · Recruiting · Simcha IL-18, Inc. · Scottsdale, Arizona